Clinical testing of the first implantable device combining cardiac contractility modulation with cardioversion/defibrillation is underway following the world’s first implantation of the device at Cleveland Clinic.
CRT Upgrade Procedures Deliver Outcomes Similar to New CRT Implants With No Excess Complications
A large new Cleveland Clinic study refutes the long-held belief that cardiac resynchronization therapy upgrade procedures carry more risk and are less successful than de novo implants.
Patients Know Less Than They Think About Their CIEDs, Survey Finds
Most patients with cardiac implantable electronic devices lacked some degree of basic knowledge of their device in a Cleveland Clinic study. They also reported a desire to use more of their device’s data features.
WRAP-IT Substudy Provides Strong Prospective Support for CIED Infection Prevention
A prespecified analysis of the 7,000-patient international trial reveals just how large of a clinical and economic burden is posed by infections following cardiac device implantations, revisions and upgrades.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
No. 7 Medical Innovation for 2020: Antibiotic Envelope for Cardiac Implantable Devices
An antibiotic envelope to help prevent infection of cardiac implantable devices will be the No. 7 most influential medical innovation for 2020, predict experts at Cleveland Clinic.
Analysis Offers Needed Benchmark Data on Post-Cardiac Surgery CIED Use
Researchers tapped a huge Cleveland Clinic database for an updated picture of factors surrounding the need for — and outcomes of — cardiac electronic device placement after heart surgery. Here’s what they learned.
CIED Infections: Know Your Enemy
One in three patients with CIED infections referred to Cleveland Clinic for extraction in recent years had methicillin-resistant staphylococci. Here’s why that’s worrisome and what can be done.